|Articles|May 1, 2006
- Volume 0 0
Venofer (iron sucrose injection, USP)
Advertisement
American Regent Inc(Shirley, NY) recentlyreceived FDA approval for2 new indications forVenofer. The product wasinitially approved for use in the treatmentof iron deficiency anemia inhemodialysis (HD) patients receivingan erythropoietin. Venofer now also isindicated for the treatment of irondeficiency anemia in peritoneal dialysis(PD) patients receiving an erythropoietinand in nondialysis chronic kidneydisease (CKD) patients receiving ornot receiving an erythropoietin. Theproduct can be administered via anintravenous push (100-mg [HD] and 200-mg [CKD] doses) or by infusion (300- and400-mg doses [PD]) depending on theindication. Venofer is available in 100-mg/5-mL single-dose vials. For moreinformation, visit www.venofer.com, orcall 800-645-1706.
Articles in this issue
about 20 years ago
A Good Night's Rest—Helping the Patient with Insomniaabout 20 years ago
Is Sleep-Driving for Real?about 20 years ago
Painful Diabetic Neuropathy: Alternative Treatmentsabout 20 years ago
A New Day Dawns for NCPA and NACDSabout 20 years ago
compounding HOTLINEabout 20 years ago
RESPy AWARDabout 20 years ago
ULM STUDENT NEEDED TO HELPabout 20 years ago
Must an Embezzling Pharmacist Repay Wages Received?about 20 years ago
Web-based Program Aids Health Care Industryabout 20 years ago
Depression: Identifying Symptoms and Appropriate TreatmentAdvertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Priority Review to Finerenone for Chronic Kidney Disease in Adults With Type 1 Diabetes
2
Expanding the Field: Who Now Qualifies for CGM, AID, and Continuous Ketone Monitoring?
3
Depression Common in Asthma, But Moderate to Severe Disease Worsens Outcomes
4
FDA Approves Bulevirtide-gmod as First-Ever Treatment for Chronic Hepatitis Delta Virus Infection
5